All posts tagged: Eli Lilly

Why Trump has launched the TrumpRx website to cut prescription drug prices | World News

Why Trump has launched the TrumpRx website to cut prescription drug prices | World News

President Donald Trump speaks about TrumpRx in the South Court Auditorium in the Old Eisenhower Executive Office Building on the White House campus. (Photo: AP) US President Donald Trump has launched a new website, TrumpRx.gov, aimed at lowering the cost of prescription medicines for Americans, Reuters reported. The move is part of Trump’s wider effort to push drugmakers to reduce prices in the United States, where patients often pay far more than in other developed countries. Announcing the site at the White House, Trump said: “People are going to save a lot of money.” Who is involved The website was unveiled alongside Dr Mehmet Oz, head of the Centers for Medicare and Medicaid Services, and Joe Gebbia, Airbnb co-founder and director of the National Design Studio. President Donald Trump speaks about TrumpRx in the South Court Auditorium in the Old Eisenhower Executive Office Building on the White House campus, Thursday, Feb. 5, 2026, in Washington, as Centers for Medicare & Medicaid Services administrator Dr. Mehmet Oz listens. (AP Photo/Alex Brandon) Sixteen major drug companies have …

Eli Lilly’s Weight Loss, Anti-Diabetes Drug Mounjaro To Be Launched In 2025

Eli Lilly’s Weight Loss, Anti-Diabetes Drug Mounjaro To Be Launched In 2025

Last Updated:December 17, 2024, 12:30 IST Not just Tirzepatide, the company plans to launch multiple newly developed products from its global portfolio in the Indian market, including cardiometabolic health, oncology, immunology and neuroscience Mounjaro, a weekly injectable drug by Eli Lilly for treating type 2 diabetes and obesity, competes with another high-profile drug, Ozempic. (Representational pic) Eli Lilly, a US-based pharmaceutical giant, plans to launch its drug, Tirzepatide, sold under the brand name Mounjaro, in the Indian market next year. Mounjaro, a weekly injectable drug by Eli Lilly for treating type 2 diabetes and obesity, competes with another high-profile drug, Ozempic (manufactured by Danish drugmaker, Novo Nordisk). The latter, brand name Ozempic (semaglutide), has not yet been launched in the Indian market. “We aim to launch Tirzepatide in India by 2025, after obtaining all necessary regulatory approvals,” Vineet Gupta, associate vice president and managing director of Eli Lilly (India), told News18. However, he said that the company hasn’t yet “finalised the pricing of Tirzepatide for India”. Gupta did not reveal its pricing strategy for the …